The epidemiology of ALS: a conspiracy of genes, environment and time
暂无分享,去创建一个
[1] O. Hardiman,et al. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: A population‐based case–control cohort study of familial and sporadic amyotrophic lateral sclerosis , 2013, Annals of neurology.
[2] O. Hardiman,et al. Age at onset of amyotrophic lateral sclerosis is proportional to life expectancy , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[3] R. Holman,et al. Amyotrophic lateral sclerosis/motor neuron disease deaths in the United States, 1999–2009 , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[4] D. Morris,et al. Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing , 2013, Journal of Medical Genetics.
[5] O. Hardiman,et al. Cognitive changes predict functional decline in ALS , 2013, Neurology.
[6] R. Holman,et al. Incidence of amyotrophic lateral sclerosis among American Indians and Alaska natives. , 2013, JAMA neurology.
[7] L. Goldstein,et al. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment , 2013, The Lancet Neurology.
[8] C. Ki,et al. Analysis of the C9orf72 hexanucleotide repeat expansion in Korean patients with familial and sporadic amyotrophic lateral sclerosis , 2013, Neurobiology of Aging.
[9] M. Thun,et al. Premorbid body mass index and risk of amyotrophic lateral sclerosis , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[10] F. Clavel-Chapelon,et al. Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis , 2013, Neurology.
[11] L. H. van den Berg,et al. Lifetime physical activity and the risk of amyotrophic lateral sclerosis , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[12] A. Chiò,et al. Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995–2009 , 2013, Journal of Neurology.
[13] J. Clarimón,et al. Analysis of the C9orf72 Gene in Patients with Amyotrophic Lateral Sclerosis in Spain and Different Populations Worldwide , 2013, Human mutation.
[14] A. Chiò,et al. Amyotrophic lateral sclerosis in Piedmont (Italy): A Bayesian spatial analysis of the incident cases , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[15] Rosa Rademakers,et al. How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders? , 2012, Current opinion in neurology.
[16] Chi-shin Hwang,et al. Riluzole and Prognostic Factors in Amyotrophic Lateral Sclerosis Long-term and Short-term Survival: A Population-Based Study of 1149 Cases in Taiwan , 2012, Journal of epidemiology.
[17] M. Benatar,et al. Utility of Capture-Recapture Methodology to Assess Completeness of Amyotrophic Lateral Sclerosis Case Ascertainment , 2012, Neuroepidemiology.
[18] Hitoshi Takahashi,et al. Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72 , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[19] P. Tsai,et al. A hexanucleotide repeat expansion in C9ORF72 causes familial and sporadic ALS in Taiwan , 2012, Neurobiology of Aging.
[20] S. Tsuji,et al. C9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of Japan. , 2012, Archives of neurology.
[21] Olubunmi Abel,et al. ALSoD: A user‐friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics , 2012, Human mutation.
[22] L. H. van den Berg,et al. Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study. , 2012, American journal of epidemiology.
[23] Michelle K. Lupton,et al. The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder , 2012, European Journal of Human Genetics.
[24] A. Al-Chalabi,et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study , 2012, The Lancet Neurology.
[25] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[26] A. Al-Chalabi,et al. A proposed staging system for amyotrophic lateral sclerosis , 2012, Brain : a journal of neurology.
[27] T. Hortobágyi,et al. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS , 2011, Acta Neuropathologica.
[28] M. Druet‐Cabanac,et al. Contribution of geolocalisation to neuroepidemiological studies: Incidence of ALS and environmental factors in Limousin, France , 2011, Journal of the Neurological Sciences.
[29] Ammar Al-Chalabi,et al. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? , 2011, Nature Reviews Neurology.
[30] A. Al-Chalabi,et al. The risk to relatives of patients with sporadic amyotrophic lateral sclerosis , 2011, Brain : a journal of neurology.
[31] C. Lewis,et al. Modelling the Effects of Penetrance and Family Size on Rates of Sporadic and Familial Disease , 2011, Human Heredity.
[32] O. Hardiman,et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study , 2011, Journal of Neurology, Neurosurgery & Psychiatry.
[33] Leonard H van den Berg,et al. Population based epidemiology of amyotrophic lateral sclerosis using capture–recapture methodology , 2011, Journal of Neurology, Neurosurgery & Psychiatry.
[34] Janel O. Johnson,et al. Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene. , 2011, Archives of neurology.
[35] M. P. de la Paz,et al. Increase in motor neuron disease mortality in Spain: Temporal and geographical analysis (1990–2005) , 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[36] O. Hardiman,et al. Proposed criteria for familial amyotrophic lateral sclerosis , 2011, Amyotrophic Lateral Sclerosis.
[37] L. H. van den Berg,et al. Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.
[38] M. Thun,et al. Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts. , 2011, Archives of neurology.
[39] A. Al-Chalabi,et al. Low index-to-ring finger length ratio in sporadic ALS supports prenatally defined motor neuronal vulnerability , 2011, Journal of Neurology, Neurosurgery & Psychiatry.
[40] T. Tango,et al. Temporal trends and geographic clusters of mortality from amyotrophic lateral sclerosis in Japan, 1995–2004 , 2010, Journal of the Neurological Sciences.
[41] O. Hardiman,et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[42] R. Bidigare,et al. Prominent Human Health Impacts from Several Marine Microbes: History, Ecology, and Public Health Implications , 2010, International journal of microbiology.
[43] R. Howard,et al. Metastatic choriocarcinoma , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[44] A. Al-Chalabi,et al. An estimate of amyotrophic lateral sclerosis heritability using twin data , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[45] L. Goldstein,et al. The sex ratio in amyotrophic lateral sclerosis: A population based study , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[46] U. Ekelund,et al. Validation of the historical adulthood physical activity questionnaire (HAPAQ) against objective measurements of physical activity , 2010, The international journal of behavioral nutrition and physical activity.
[47] A Al-Chalabi,et al. Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[48] O. Hardiman,et al. The epidemiology of motor neuron disease in Northern Ireland using capture-recapture methodology , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[49] R. Pamphlett. STUDY OF 962 PATIENTS INDICATES PROGRESSIVE MUSCULAR ATROPHY IS A FORM OF ALS , 2010, Neurology.
[50] J. Feussner,et al. Neurological mortality among Gulf War veterans. , 2010, American journal of industrial medicine.
[51] M. Hernán,et al. Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study , 2010, BMC neurology.
[52] 鮫島 浩,et al. Population-based study からみた神経予後不良因子の検討 , 2009 .
[53] C. Armon. Smoking may be considered an established risk factor for sporadic ALS , 2009, Neurology.
[54] Daniel Stahl,et al. Latent Cluster Analysis of ALS Phenotypes Identifies Prognostically Differing Groups , 2009, PloS one.
[55] Han K. Kang,et al. Neurological mortality among U.S. veterans of the Persian Gulf War: 13-year follow-up. , 2009, American journal of industrial medicine.
[56] E. Beghi,et al. Incidence of amyotrophic lateral sclerosis in Europe , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[57] L. H. van den Berg,et al. A long-term prospective study of the natural course of sporadic adult-onset lower motor neuron syndromes. , 2009, Archives of neurology.
[58] G. Logroscino,et al. Reduced frequency of ALS in an ethnically mixed population , 2009, Neurology.
[59] A. Al-Chalabi,et al. Natural history and clinical features of the flail arm and flail leg ALS variants , 2009, Neurology.
[60] Xun Hu,et al. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.
[61] J L Haines,et al. Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .
[62] P. Preux,et al. Prognosis of ALS: Comparing data from the Limousin referral centre, France, and a Uruguayan population , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[63] D. Mash,et al. Beyond Guam: The cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[64] L. H. van den Berg,et al. What we truly know about occupation as a risk factor for ALS: A critical and systematic review , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[65] O. Hardiman,et al. An all‐Ireland epidemiological study of MND, 2004–2005 , 2009, European journal of neurology.
[66] L. H. van den Berg,et al. Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: A systematic review , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[67] E. Beghi,et al. Prognostic factors in ALS: A critical review , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[68] A. Al-Chalabi,et al. Geographical Clustering of Amyotrophic Lateral Sclerosis in South-East England: A Population Study , 2008, Neuroepidemiology.
[69] K. Thennarasu,et al. Clinical characteristics and survival pattern of 1153 patients with amyotrophic lateral sclerosis: Experience over 30 years from India , 2008, Journal of the Neurological Sciences.
[70] C. Armon. Sports and trauma in amyotrophic lateral sclerosis revisited , 2007, Journal of the Neurological Sciences.
[71] Hiroyuki Nodera,et al. [New diagnostic criteria of ALS (Awaji criteria)]. , 2007, Brain and nerve = Shinkei kenkyu no shinpo.
[72] P. Comba,et al. Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data , 2007, European Journal of Epidemiology.
[73] J. Alappat. ETHNIC VARIATION IN THE INCIDENCE OF ALS: A SYSTEMATIC REVIEW , 2007, Neurology.
[74] P. Gordon,et al. Lou Gehrig, Rawhide, and 1938 , 2007, Neurology.
[75] A. Al-Chalabi,et al. Three soccer playing friends with simultaneous amyotrophic lateral sclerosis , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[76] T. Hortobágyi,et al. Electrical injury and amyotrophic lateral sclerosis: a systematic review of the literature , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[77] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[78] H. Mitsumoto,et al. The natural history of primary lateral sclerosis , 2006, Neurology.
[79] S. Grambow,et al. Estimating the Occurrence of Amyotrophic Lateral Sclerosis among Gulf War (1990–1991) Veterans Using Capture-Recapture Methods , 2005, Neuroepidemiology.
[80] A. Chiò,et al. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. , 2005, Brain : a journal of neurology.
[81] M. Thun,et al. Prospective study of military service and mortality from ALS , 2005, Neurology.
[82] S. Ho,et al. An epidemiological study of motor neuron disease in Hong Kong , 2005, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[83] M. Thun,et al. Prospective study of cigarette smoking and amyotrophic lateral sclerosis. , 2004, American journal of epidemiology.
[84] Paul Alan Cox,et al. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[85] E. Beghi,et al. The sinister side of Italian soccer , 2003, The Lancet Neurology.
[86] S. Grambow,et al. Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations , 2003, Neurology.
[87] Paul Alan Cox,et al. Biomagnification of cycad neurotoxins in flying foxes , 2003, Neurology.
[88] A C Gatrell,et al. Spatial clustering of amyotrophic lateral sclerosis in Finland at place of birth and place of death. , 2003, American journal of epidemiology.
[89] Y. Stern,et al. Premorbid weight, body mass, and varsity athletics in ALS , 2002, Neurology.
[90] W. Longstreth,et al. Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption. , 2000, American journal of epidemiology.
[91] W. Longstreth,et al. Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. II. Diet. , 2000, American journal of epidemiology.
[92] J. De Pedro-Cuesta,et al. Differential features of motor neuron disease mortality in Spain. , 1997, International journal of epidemiology.
[93] P. Leigh,et al. Motor neuron disease. , 1994, Springer London.
[94] B. Brooks,et al. El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.
[95] P N Leigh,et al. The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study. , 1993, Brain : a journal of neurology.
[96] B. Pant,et al. Amyotrophic lateral sclerosis (ALS): A phylogenetic disease of the corticomotoneuron? , 1992, Muscle & nerve.
[97] A. Chiò,et al. Motor neuron disease in the province of Turin, Italy, 1966–1980 Survival analysis in an unselected population , 1984, Journal of the Neurological Sciences.
[98] THE AMYOTROPHIC LATERAL SCLEROSIS OF GUAM , 1966, The Medical journal of Australia.
[99] L. Kurland,et al. Epidemiologic Investigations of Amyotrophic Lateral Sclerosis , 1955, Neurology.
[100] Mulder Dw,et al. Neurologic diseases on the island of Guam. , 1954 .
[101] L. Kurland,et al. Epidemiologic Investigations of Amyotrophic Lateral Sclerosis , 1954, Neurology.
[102] V. Palladino,et al. Amyotrophic lateral sclerosis; fifty cases observed on Guam. , 1953, The Journal of nervous and mental disease.
[103] D. R. Koerner. AMYOTROPHIC LATERAL SCLEROSIS ON GUAM: A CLINICAL STUDY AND REVIEW OF THE LITERATURE , 1952 .
[104] C. Aring,et al. A CRITICAL REVIEW , 1939, Journal of neurology and psychiatry.
[105] J. Snow. On the Mode of Communication of Cholera , 1856, Edinburgh medical journal.
[106] Cheng-Li Lin,et al. A population-based cohort study. , 2015 .
[107] Emily Hoch,et al. – a review of the scientific literature , 2013 .
[108] A. Banerjee,et al. A 10-year prospective population-based study of the incidence and outcome of acute abdominal aortic aneurysms: implications for screening , 2013 .
[109] Presumption of service connection for amyotrophic lateral sclerosis. Final rule. , 2009, Federal register.
[110] W. Bradley,et al. The ALS/PDC syndrome of Guam and the cycad hypothesis. , 2009, Neurology.
[111] George Turabelidze,et al. An epidemiologic investigation of amyotrophic lateral sclerosis in Jefferson County, Missouri, 1998-2002. , 2008, Neurotoxicology.
[112] A. Al-Chalabi,et al. Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). , 2007, Neuroepidemiology.
[113] J. Manson,et al. Prospective Study of , 2007 .
[114] A. Al-Chalabi,et al. Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. , 2006, Journal of neurology.
[115] S. Gabriel,et al. Systematic Review of the Literature , 2021, Adherence to Antiretroviral Therapy among Perinatal Women in Guyana.
[116] Mulder Dw. Clinical limits of amyotrophic lateral sclerosis. , 1982 .
[117] L. Kurland,et al. Neurologic diseases on the island of Guam. , 1954, United States Armed Forces medical journal.
[118] Jm Charcot,et al. Deux cas d’atrophie musculaire progressive avec lesions de la substance grise et des faisceaux antero-lateraux de la moelle epiniere , 1869 .